Mini Symposia Presentations
Start Date
20-5-2014 4:00 PM
Description
Mounting evidence suggests that particular aspects of human health and disease may be attributable to the trillions of microbes that inhabit our gastrointestinal tract, collectively referred to as the gut microbiota. Evidence suggests that pathologic changes to the microbiota (termed “dysbiosis”) are associated with a wide variety of medical outcomes, and therefore therapeutic manipulation of the microbiota is a major area of research interest. As part of the mini-symposium entitled "Manipulating the Gut Microbiome for Human Health," Dr. Olendzki presents on the Inflammatory Bowel Disease Anti-Inflammatory Diet (IBD-AID).
Keywords
Inflammatory Bowel Disease, IBD, diet
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License.
Included in
Dietetics and Clinical Nutrition Commons, Digestive System Diseases Commons, Food Microbiology Commons, Gastroenterology Commons, Nutrition Commons, Translational Medical Research Commons
The Guts and Bolts of the Diet and a Look into the Microbiome
Mounting evidence suggests that particular aspects of human health and disease may be attributable to the trillions of microbes that inhabit our gastrointestinal tract, collectively referred to as the gut microbiota. Evidence suggests that pathologic changes to the microbiota (termed “dysbiosis”) are associated with a wide variety of medical outcomes, and therefore therapeutic manipulation of the microbiota is a major area of research interest. As part of the mini-symposium entitled "Manipulating the Gut Microbiome for Human Health," Dr. Olendzki presents on the Inflammatory Bowel Disease Anti-Inflammatory Diet (IBD-AID).
Comments
Presented at the 2014 UMass Center for Clinical and Translational Science Research Retreat, held on May 20, 2014 at the University of Massachusetts Medical School, Worcester, Mass.